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WHICH USEFUL TOXICOLOGICAL INFORMATION CAN BE DRAWN
FROM STUDIES ON THE HEPATIC FIXATION OF ANTICOAGULANT
RODENTICIDES
J.C. LECHEVIN and A. VIGIE, Centre de recherche LIPHA, 115 avenue Lacassagne, 69003 Lyon, France
ABSTRACT: Anticoagulant rodenticides act at the hepatic level where they are more or less fixed according to their
lipophilic nature. The studies on kinetics and metabolism carried out with no toxic doses are useful to know how products act
but do not allow to anticipate the toxicity risks for non target species, because of low residual contents. These risks can only be
assessed after the administration of toxic doses taking into account the residue levels. The use of half-life to express the results
is not sufficiently accurate and may lead to wrong conclusions. The studies involving the residue and secondary toxicity levels
are more accurate for assessing the risks. Some examples are given in particular for bromadiolone.
Proc. 15th Vertebrate Pest Conf. (J. E. Borrecco & R. E. Marsh,
Editors) Published at University of Calif., Davis. 1992

INTRODUCTION
Anticoagulant rodenticides exert their antivitamin K
effect at the hepatic level by preventing the transformation
of vitamin K epoxide into reduced vitamin K. Coagulation
factors depending on vitamin K being no longer activated,
blood coagulation does not work properly and induces the
onset of internal haemorrhages (Figure 1, Meehan 1984).
The hepatic fixation of anticoagulant rodenticides varies in time according to products. It seems closely related to
the lipophilic nature of the molecule and that explains the
more potent activity of products called second generation
products. Therefore, bromadiolone turns out to be more lipophilic than warfarin because of the length and structure of its
side chain; presence of 2 phenyl rings and a bromine atom
(Figure 2).
The first data on the hepatic behaviour of products are
given by the studies on kinetics and metabolism classically
carried out on lab rodent strains which are given low but no
lethal doses in order to keep animals in life as long as necessary. These studies interesting for the knowledge of products
are not adequate to surround the risk for non target species.
Trials very similar to fight conditions must be added; lethal
doses administered, where relevant to wild rodent strains.
It is also classical to express the result of kinetic studies
by calculating the half-lives and in particular the hepatic
half-life. This way of calculating is not appropriate to the
knowledge of risk for non target species and moreover varies according to different factors. So, residue levels must
be taken into account and toxicological consequences
involved must be examined. These various points are going
to be developed through some examples published in the
literature.
STUDIES ON KINETICS AND
METABOLISM—RELATION BETWEEN
RESIDUE LEVELS AND TOXICITY
Several studies were dedicated to the kinetics and
metabolism of flocoumafen in different species among which
the rat (Huckle et al. 1989). The oral administration of a subtoxic dose: 0.14 mg/kg (LD50 0.25 mg/kg) of 14C flocoumafen shows that the behaviour of the product is the same as
other anticoagulant rodenticides, in particular a preferential
storage in the liver: about 50 percent of the administered
dose. The hepatic concentration is about 1.2 µg/g of liver

during the first 7 days and then slowly decreases and remains
higher than 0.5 jag of liver 200 days after the administration.
Assuming that the rats' liver of this experiment weighs 7 g on
average, the maximum residual flocoumafen dose is 8.4 µg.
This concentration may not have any toxic effect on non target
species even on the most sensitive ones like the dog: LD50
between 0.075 and 0.25 mg/kg (Johnson et al. 1986 mentioned
in Lund 1988). In the worst case, LD50: 0.075 mg/kg corresponds to a single absorption by a 10-kg dog of about 10 kg of
poisoned rodents assuming that the liver contains 50 percent
of the administered flocoumafen dose. This event is impossible (Figure 3).

Figure 1. Simplified diagram of blood coagulation.

Figure 2. Comparison of the structures of warfarin and bromadiolone side chains emphasizing the more lipophilic nature of
bromadiolone.
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Table 1. Bromadiolone residues in different target species
after the administration of toxic doses.

Figure 3. Liver flocoumafen residues and toxicity for the dog.

Figure 4. Brodifacoum, bromadiolone: liver residues and toxicity for the dog (Brodifacoum - Godfrey et al. 1981, Bromadiolone - Poché 1988).

Table 2. Study of liver storage of difethialone. R correlation
coefficient between study time and deviations between recorded concentration and assessed concentration.

The same conclusion may be drawn from the comparative study of liver storage carried out with 4 anticoagulant
rodenticides: brodifacoum, bromadiolone, coumatetralyl, and
difenacoum 14C (Parmar et al. 1987). The authors indicate that
the elimination of products from liver is biphasic, an initial,
rapid phase lasting up to 8 days followed by a second very
slower phase lasting up to several months depending on products. During the second phase, the concentrations for
brodifacoum and bromadiolone for which the metabolism is
low are 2-3 nmoles equivalent/g of liver, that is to say 1 to 1.6
(µg/g. It is not specified in this summarized publication to
which study time these values correspond to. If as previously
seen, it is assumed that a rat's liver weighs 7 g, the total
quantity of products: 7 to 11.2 µg may have no toxic consequences for the dog, for instance when the single maximum
tolerated doses by this species are taken into account (Figure 4).
These 2 examples show very clearly that the studies on
kinetics and metabolism carried out with no toxic doses give
residue levels which do not allow to anticipate the toxicity
risk for non target species.

The administration of toxic doses gives low but quite
significant residuary levels of brodifacoum and bromadiolone
of about some ppm. In the kinetic study carried out with
flocoumafen, assuming that 50 percent of the product is concentrated in the liver, the maximum residual concentration
only represents a small proportion of ppm (0.07 mg/kg).

RESIDUE LEVELS AFTER ADMINISTRATION
OF TOXIC DOSES
The assay of anticoagulant rodenticide residues in rodents poisoned with lethal doses, therefore under normal conditions of struggle, is preferably made in the whole animal.
For bromadiolone, in order to study the secondary toxicity for stoat (Mustela erminea) and common buzzard (Buteo buteo), water voles (Arvicola terrestris) were poisoned
under different conditions and in particular under conditions
similar to those of struggle: a 3-day carrot bait consumption
titrated at 100 mg/kg of active ingredient (Grolleau et al.
1989). After a 3-day bait consumption, the quantity of
bromadiolone found in the whole animal is quite significant:
10.93 mg/kg and then quickly decreases: 1.29 mg/kg in the
following 2 days. Analyses made on rodents found killed
after fields trial confirm the residue levels (Poche 1988). So,
for a trial performed in Chino, California, the average residual content in bromadiolone was 1.92 mg/kg for the roof
rat and 1.17 mg/kg for the mouse. These results are summarized in Table 1.
A similar quantity of residues (2.2 to 5.2 mg/kg) was
found for voles (Microtus pinetorum) poisoned for 3 days
with a bait titrated at 50 mg/kg of brodifacoum and then
sacrificed on day 4 (Kaukeinen 1982).

STUDY ON KINETICS AND METABOLISM—
RESULTS EXPRESSED
The elimination curve is an exponential and must be, for
the calculation of half-life, drawn in a semi-logarithmic system (log of concentrations).
Choosing a mathematical model requires a lot of attention as shown by the following example from an unpublished
study on liver storage with difethialone (Vigie 1989). The
mathematical parameters calculated through the SIPHAR/PC
software are summarized in Table 2.
Although the correlation coefficient is slightly better in
the model with 2 exponentials, the system with 1 exponential
for which the relative standard deviations are the lowest ones
must be chosen. This choice has some consequences on the
half-life: 73 days (model with 1 exponential) instead of 159
days (model with 2 exponentials, second half-life).
The number of experimental points, therefore the study
time may also act upon the value of half-life. So, in the previous trial, the 73-day value corresponding to a 6-month study
is shortened to 51 days if the study is stopped 3 months after.
Finally, the only half-life values taken into account may
lead to wrong conclusions. So, in the study carried out by
Parmar et al. (1987), it is mentioned that brodifacoum and
bromadiolone have hepatic half-lives of 130 and 170 days
respectively, which may make believe that the hepatic fixation of bromadiolone is higher. It is actually the contrary, as
shown by a comparative study carried out on a lab rat strain
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Table 3. Secondary toxicity of bromadiolone.

which was given a LD50 of each product (Ray et al. 1989).
For the 3 rats administered 1.25 mg/kg of bromadiolone (dose
slightly higher than LD50: 1.125 mg/kg) and sacrificed 5 days
later, the hepatic content is lower than 0.06 µg/g of liver
(detection limit). For brodifacoum (LD50 0.28 mg/kg), the
contents 7 days after the administration are 0.4 and 2.2 µ/g
of liver for 2 rats out of 3. It is therefore very clear that the
value of half-life is not a sufficient accurate way for expressing results to allow to anticipate the secondary toxicity risk.
Only the taking into account of residue levels allows it.

ies on kinetics and metabolism may have made believed a
similar toxicity have in fact quite different behaviours, very
probably related to different residue levels.

RESIDUE LEVELS AFTER THE ADMINISTRATION OF TOXIC DOSES—TOXICOLOGICAL
CONSEQUENCES
The studies measuring residues in association with the
assay of secondary toxicity allow to precisely determine the
toxicological consequences for non target species. Table 3
summarizes some of the secondary toxicity results of
bromadiolone for the buzzard and stoat in the study carried
out by Grolleau et al. (1989). Mortality is only recorded in
case of repeated administration of rodents.
The absence of bromadiolone toxicity with a single ingestion of poisoned rodent was also noted for the fox, the
supposed predator of the coypu (Morin 1988). We must be
under severe experimental conditions - administration of coypus poisoned by bromadiolone bait until death that is to say
for 5 to 6 days - in order to record mortality.
Other studies on secondary toxicity, without assaying
residues in poisoned rodents, allowed to confirm the low
toxicity of bromadiolone and to put forward differences between products. So, in the study on toxicity for the owl (Tyto
alba) carried out by Mendenhall et al. (1980), the 6-day administration of poisoned rodents by bromadiolone does not
induce any sign of poisoning. Rodents must be given for 10
days before noting the death of 1 bird out of 2. Under the
same conditions, difenacoum which has a half-life similar to
bromadiolone in classical kinetic studies (Parmar et al. 1987)
induces haemorrhages without mortality after a 6-day administration. For brodifacoum, the mortality of the 2 birds is
recorded after a 3-day administration of poisoned rodents. In
the same way, the stone martens' consumption (Martesfoina)
of 7 to 8 field mice a day during 4 days (total 31), poisoned
during 4 days by a bromadiolone bait titrated at 50 mg/kg
shows no consequence. Stone martens do not show any
sign of poisoning (Lund et al. 1986). As a result, these
experiments show that the toxicity risk for non target species
is more significant in the case of repeated consumption of
poisoned rodents. Different sensitivities must be noted among
non target species. On another hand, products for which stud206

CONCLUSION
It is important to make a clear difference of the usefulness of studies on kinetics in target rodents according to the
administered dose. Low but no lethal doses are used to know
absorption, distribution and elimination of products. They
cannot be used to foresee the risk for non target species; the
residuary contents represented by traces having no toxicological meaning. In order to know the risk for non target
species, residuary contents in poisoned rodents by lethal doses
must be known. Only the values of the first days of intoxication are important from a toxicological point of view.
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